Posted inHealth

For Diabetics, a New Insulin Inhaler Could Replace Shots as Early as 2014

[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed positive results for controlling diabetes in a late-stage clinical trial, the drugโ€™s maker, MannKind (MNKD), reported today. Pharmaceutical companies have been working on inhalable insulin for a long time on the […]

Sign up for newsletters

Get the best of The Washington Informer directly in your email inbox.

Sending to:

Gift this article